BE.BIO: Keyword Density Checker

Total words: 677 | 2-word phrases: 170 | 3-word phrases: 192 | 4-word phrases: 203

PAGE INFO

Title	Try to keep the title under 60 characters (55 characters) Be Biopharma - Advancing our science with bold humanity
Description	Try to keep the meta description between 50 - 160 characters (157 characters) Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (40 characters) Advancing our science with bold humanity

#	Keyword	Frequency	Density
1	our	16	14.29%
2	b	11	9.82%
3	the	9	8.04%
4	to	8	7.14%
5	be	7	6.25%
6	science	7	6.25%
7	cell	6	5.36%
8	publicationspresentations	6	5.36%
9	for	6	5.36%
10	patientscaregivers	5	4.46%

#	Keyword	Frequency	Density
1	engineered b cell	5	2.60%
2	b cell medicine	4	2.08%
3	our science our	3	1.56%
4	be bio our	3	1.56%
5	read more about	3	1.56%
6	science our platform	3	1.56%
7	bio our science	3	1.56%
8	publicationspresentations careers contact	2	1.04%
9	careers contact us	2	1.04%
10	medicine for the	2	1.04%
11	our company life	2	1.04%
12	company life at	2	1.04%
13	novel engineered b	2	1.04%
14	at be bio	2	1.04%
15	b what gene	2	1.04%
16	the treatment of	2	1.04%
17	our platform publicationspresentations	2	1.04%
18	a novel engineered	2	1.04%
19	be101 a novel	2	1.04%
20	orphan drug designation	2	1.04%
21	grants orphan drug	2	1.04%
22	fda grants orphan	2	1.04%
23	b cell medicines	2	1.04%
24	patientscaregivers investorsmedia news	2	1.04%
25	for the treatment	2	1.04%
26	cell medicine for	2	1.04%
27	investorsmedia news releases	2	1.04%
28	promising to do	2	1.04%
29	do in hemophilia	2	1.04%
30	in hemophilia b	2	1.04%

#	Keyword	Frequency	Density
1	our science our platform	3	1.48%
2	bio our science our	3	1.48%
3	engineered b cell medicine	3	1.48%
4	be bio our science	3	1.48%
5	to do in hemophilia	2	0.99%
6	promising to do in	2	0.99%
7	a novel engineered b	2	0.99%
8	cell therapy enters the	2	0.99%
9	b cell therapy enters	2	0.99%
10	engineered b cell therapy	2	0.99%
11	second engineered b cell	2	0.99%
12	at be bio our	2	0.99%
13	novel engineered b cell	2	0.99%
14	in hemophilia b what	2	0.99%
15	science our platform publicationspresentations	2	0.99%
16	fda grants orphan drug	2	0.99%
17	grants orphan drug designation	2	0.99%
18	be101 a novel engineered	2	0.99%
19	for the treatment of	2	0.99%
20	medicine for the treatment	2	0.99%
21	cell medicine for the	2	0.99%
22	b cell medicine for	2	0.99%
23	do in hemophilia b	2	0.99%
24	publicationspresentations careers contact us	2	0.99%
25	hemophilia b what gene	2	0.99%
26	b what gene therapies	2	0.99%
27	what gene therapies can’t	2	0.99%
28	doing to unleash the	1	0.49%
29	to unleash the immense	1	0.49%
30	unleash the immense therapeutic	1	0.49%
31	possibilities of engineered b	1	0.49%
32	of engineered b cell	1	0.49%
33	engineered b cell medicines	1	0.49%
34	for be101 a novel	1	0.49%
35	orphan drug designation for	1	0.49%
36	search forsearch button skip	1	0.49%
37	cell medicines our science	1	0.49%
38	2024 fda grants orphan	1	0.49%
39	4 2024 fda grants	1	0.49%
40	june 4 2024 fda	1	0.49%

#	URL	Whois	Check
1	https://www.linkedin.com/company/be-biopharma-inc/	Whois	linkedin.com
2	https://twitter.com/bebiopharma/	Whois	twitter.com
3	https://bebiopharma.wpenginepowered.com	Whois	wpenginepowered.com